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ABSTRACT 
Aim: We investigated the impact of vibrating acoustic airflow, the high frequency (f ≥ 100 
Hz) and the low frequency (f ≤ 45 Hz) sound waves, on the enhancement of intrasinus drug 
deposition. 
Methods: 81mKr-gas ventilation study was performed in a plastinated human cast with and 
without the addition of vibrating acoustic airflow. Similarly, intrasinus drug deposition in a 
nasal replica using gentamicin as a marker was studied with and without the superposition of 
different modes of acoustic airflow.  
Results: Ventilation experiments demonstrate that no sinus ventilation was observed without 
acoustic airflow although sinus ventilation occurred whatever the modes of acoustic airflow 
applied. Intrasinus drug deposition experiments showed that the high frequency acoustic 
airflow led to 4-fold increase in gentamicin deposition into the left maxillary sinus and to 2-
fold deposition increase into the right maxillary sinus. Besides, the low frequency acoustic 
airflow demonstrated a significant increase of 4-fold and 2-fold in the right and left maxillary 
sinuses respectively.  
Conclusion: We demonstrated the benefit of different modes of vibrating acoustic airflow for 
maxillary sinus ventilation and intrasinus drug deposition. The degree of gentamicin 
deposition varies as a function of frequency of the vibrating acoustic airflow and the geometry 
of the ostia.  
 
Keywords: vibrating acoustic airflow, high frequency, low frequency, intrasinus deposition, 
81mKr-gas ventilation. 
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1. Introduction 
Rhinosinusitis is an inflammatory disorder involving the lining of the nasal passages and the 
paranasal sinuses. Sinuses are poorly ventilated cavities within the bones of the face 
communicating with the nasal fossa via the maxillary ostium (Tarhan et al., 2005; Jones, 
2001; Fokkens et al., 2012). Chronic rhinosinusitis (CRS) is one of the most common chronic 
diseases, affecting about 10-15% of the total population with significant impact on quality of 
life and health care expenditure, and economic impact in terms of absenteeism and 
productivity (Durand et al., 2011a; Laube et al., 2011). CRS is being defined as the presence 
of two or more symptoms, such as nasal blockage, obstruction, congestion or nasal discharge 
(anterior or posterior) (Dykewicz and Hamilos, 2010). Compared with people without 
rhinosinusitis, those with this disease reported more days spent bedridden and more visits to 
healthcare providers. These findings highlight the significant impact of this health problem on 
patient quality of life, as well as costs of care to patients and society (Benninger et al., 2010). 
One of the primary interests of treatment of this disease is to improve the quality of life of the 
patients and to reduce the considerable financial burden. CRS patients are currently treated 
according to guidelines, where finally surgery is performed after various preparative 
treatments, i.e. using nasal pump sprays. There is no standard management of CRS. 
Significant advances in management have been achieved, including endoscopic surgery, 
newer antibiotics, better diagnostic criteria, image-guided surgical navigation, and the 
avoidance of external procedures. These advances have improved the treatment of this disease 
process and, for some patients, may lead to a decrease in the frequency, severity, and duration 
of symptoms and infections. Medical therapy of CRS is a key strategy, with surgery playing a 
vital adjunctive role. There are, however, several negative factors that are still present after 
surgery, including potential offending bacteria, fungi, viruses, and the patients’ immunologic 
responses. These factors and others cause many patients to have frequent, recurrent acute 
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infections compounding their chronic sinusitis. To avoid this, studies have been redirected 
towards determining better treatments with fewer implications. An efficient topical therapy 
may allow more effective treatment of upper respiratory diseases, preventing sinus surgery or 
at least delaying the need for sinus surgery. The most frequently recommended medications 
for treatment of CRS consist in the systemic administration of antibiotics by oral route. 
Gentamicin, an aminoglycoside active on Gram-negative bacteria and staphylococci, is 
considered as one of these frequently recommended antibiotics due to its recognized efficacy 
on rhinosinusitis associated bacteria (Desrosiers et al., 2011; Kalogjera et al., 2003). The 
effectiveness of topical delivery of pulmonary antibiotics and corticosteroids through the 
nebulization process has been previously revealed in many studies (Bhattacharyya et al., 
2011; Leclerc et al., 2014a). Topical delivery, particularly nebulization, has the advantage 
over systemic therapy as it minimizes the risk of systemic side effects while increasing the 
local dose. Therefore, better targeting of nebulized antibiotics into the common sites of 
infection, maxillary sinuses, could improve clinical outcomes in patients suffering from CRS 
and minimize the risk of antibiotic resistance in non-targeted areas. Despite the fact that 
maxillary sinuses are poorly-ventilated hollow organs, several studies have shown the 
efficacy of nebulized drug to treat sinus disorder (Leclerc et al., 2014a, 2014b; Durand et al., 
2012). Recently, we have studied the gentamicin deposition in the maxillary sinuses using 100 
Hz acoustic airflow nebulization. In addition, several works focused on the mechanism 
involved in sinus ventilation, which is a fundamental requirement of aerosolized drug delivery 
to the sinus cavities. The sinus ventilation and then the intrasinus drug deposition can be 
provided by medical devices enabled to generate vibrating airflows. The main objective of 
these medical devices is to add an acoustic airflow to the airborne droplets in order to 
generate a sufficient pressure gradient to allow the sinus ventilation (Durand et al., 2011a; 
Möller et al., 2011, 2010). The aim of this study is the investigation of the impact of different 
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modes of acoustic airflow on the maxillary sinus ventilation (using a radioactive gas) and the 
intrasinus drug deposition (using a gentamicin aerosol). 
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2. Materials and Methods 
2. 1. Anatomic nasal replica 
2.1.1. Human plastinated cast 
A technique that allows the preservation of most physical properties of anatomical specimens 
is known as plastination. The human plastinated cast used provides an easy access to the 
maxillary sinuses due to lateral-paramedian sections (Durand et al., 2011b). Its anatomical 
and aerodynamic behavior closely resembles in vivo patterns. Such models were previously 
characterized anatomically, geometrically and aerodynamically and were successfully used in 
several aerosol deposition studies (Durand et al., 2011a; Leclerc et al., 2014b; Moeller et al., 
2009). In this study, the plastinated nasal cast was used to perform radioactive gas ventilation 
experiments using 81mKr-gas. 
 
2.1.2. Nasal replica 
A nasal replica was created using a stereolithography technique leading to manufacturing of a 
transparent, water-resistant, non-porous resin replica of the human plastinated cast (Leclerc et 
al., 2014b ; co-development with the DTF medical company). Anatomical and aerodynamic 
similarities between the nasal replica of the plastinated nasal cast, particularly the geometry of 
the ostia and maxillary sinuses, was confirmed after performing endoscopy and CT scans. The 
differences in the dimensions of the individual maxillary ostia (6 mm long with a 2 mm 
diameter for the RMS and 2 mm long with a 5 mm diameter for the LMS) possessed by the 
plastinated human cast were reproduced in the nasal replica thanks to a stereolithography 
technique (Leclerc et al., 2014b). In this study, the nasal replica was used to perform 
gentamicin aerosol deposition experiments. Compared to the human plastinated cast and 
human in vivo experiments, nasal replica was approved to be used in aerosol deposition study 
facilitating the washing technique and reducing the drying time (Le Guellec et al., 2014). 
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2.2. Nebulizing systems 
Two nebulizing conditions were studied. The first one delivers a high frequency vibrating 
acoustic airflow; we define a high frequency acoustic airflow as an acoustic airflow of 100 Hz 
and above. The commercial medical device used was the ATOMISOR NL11 jet nebulizer 
associated with an AOHBOX compressor (DTF Medical, Saint-Etienne, France). A nasal plug 
(C28, DTF Medical, Saint-Etienne, France) attached to the nebulizer ensured its interface 
connection with nasal replica’s nostrils. Nebulization can be performed with or without the 
addition of the high frequency acoustic pressure waves by using these two possible modes 
offered with this commercial medical device.  
The second nebulizing condition consists in superimposing a low frequency vibrating acoustic 
pressure wave to the aerosol production; we define low frequency acoustic airflow as an 
acoustic airflow of frequency of 45 Hz and above. The commercial device used was the PARI 
SINUS jet nebulizer associated with a PARI SINUS compressor (Pari GmbH, Starnberg, 
Germany). Vibrating and non-vibrating airflow nebulizations were performed by connecting 
and disconnecting the vent tubing from the vibration output of the compressor. For aerosol 
delivery to the nasal fossa, this nebulizer was coupled to the same nasal plug used in the first 
nebulizing conditions. Thus, the low frequency device was not used according to producer 
specifications (i.e. one nostril in, the other out). In fact, as the aim of this work was the impact 
of acoustic airflow on intrasinus drug delivery; we needed a same experimental protocol of 
aerosol administration to the nasal fossa for both low and high frequency devices to avoid 
biases due to the impact of the nasal plug. Thus, we must underline that the results of 
intrasinus drug deposition for the low frequency device cannot be representative of data 
obtained in vivo according to the producer specifications.  
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2.3. Scintigraphic study of the sinus ventilation 
81mKr-gas continuously administered via nasal plug through the human plastinated cast was 
performed in order to study the impact of the different modes of acoustic airflow on the 
radioactive gas penetration into the maxillary sinuses (81 Rubidium / 81m Krypton generator, 
COVIDIEN IMAGING FRANCE). Ventilation experiments were performed in front of a 
single-head planar gamma camera (Millennium MPR Gamma Camera; GE healthcare) 
equipped with a low-energy, high-resolution collimator. 
Each nebulizer was coupled to both nostrils of the model via a nasal plug (Fig. 1). The output 
channel of the 81mKr-gas generator was directly connected to the compressed air pressure 
supply tubing of the nebulizer. Two movable plates were used to close the maxillary sinuses 
hermetically during the 81mKr-gas ventilation experiments (Durand et al., 2001). Several 
experiments were performed with and without the two types of acoustic airflow (low and high 
frequency acoustic airflow) with each nebulizer. Anterior static images of 81mKr-gas 
ventilation were acquired (matrix 128*128 with a target of 100 Kcnts per acquisition). 
Trachea of the model was tightly clogged to avoid the radioactive 81mKr-gas contamination 
and thus to reduce the noise in scintigraphic images. Acquired images of the gamma camera 
were analyzed using a Xeleris 2 workstation (GE Healthcare). Images were processed with 
the same windowing and filtration level. 
 
2.4. Aerosol depositions into the maxillary sinuses 
Gentamicin (GENTAMICINE PANPHARMA 160 mg – 2 ml; 80 mg/ml) was used as a 
marker. It was chosen due to its efficacy recognized on rhinosinusitis associated bacteria. The 
nebulizers were filled with 4 ml of a gentamicin solution operating at a flow rate of 8 L.min−1. 
The maxillary sinuses of the nasal replica were hermetically sealed during the experiments. 
The nasal replica was connected to a 15 cm long tube simulating the trachea equipped with an 
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absolute filter. Nebulization lasted 10 minutes. After each nebulization, the plates closing the 
sinuses were then removed and the maxillary sinuses were flushed four times by syringe 
containing 1 ml of physiological water (Durand et al., 2011a). Each sinus was flushed 4 times 
using the same physiological water. The region close to the maxillary ostium was never 
flushed thus avoiding the overestimation of the amount of gentamicin deposited in maxillary 
sinuses (Durand et al., 2011a). For subsequent measurement of the gentamicin concentration, 
the collected liquid was kept at -20°C. After each nebulization, the nasal replica was 
disconnected from the assembly and copiously washed with tap water and dried with pulsed 
air. Physiological water nebulizations were randomly performed throughout the experiments 
by filling the nebulizers with 4 ml of physiological water instead of gentamicin to verify the 
efficiency of model washing; i.e. the gentamicin content in the flushing liquid is lower than 
the detection level of the analyzer. Gentamicin concentrations in samples were quantified by 
fluorescence polymerization immunoassay (FPIA) with a TDxFLx® analyzer (Abbott 
Diagnostics Division, USA), which has a lower detection limit of 0.2 mg.L-1. 
 
2.5. Particle size-distribution and aerosol output characterization 
Aerosol generated by the different studied nebulizers and compressors with and without the 
effect of superimposed sound pressure waves was characterized using an electrical low-
pressure impactor (ELPI, Dekati Ltd., Finland). These experiments allow determining the 
particle sizing in terms of Mass Median Aerodynamic Diameter (MMAD). The precise 
protocol was described in previous works (Durand et al., 2011b). Briefly, we used sodium 
fluoride (NaF; 2.5%; 4 ml) as a chemical tracer according to European standard procedure 
(NF EN 13544-1). Airborne particles impact on the 12 stages of the cascade impactor; which 
allows the simultaneous measurement of the aerodynamic size. The ELPI cascade impactor 
allows the collection of nebulized particles from 7 nm to 10 µm into 12 size fractions and 
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operated with airflow of 10 L.min-1. The nebulizer was connected to the cascade impactor via 
a metal United States Pharmacopeia (USP) like artificial throat. Hence, for the particle size 
measurement, NaF was aerosolized by the nebulizer for 5 minutes after which each stage was 
washed with 5 ml of distilled water. The concentration of NaF samples was then assayed by 
electrochemical means (PerfectIONTM combined with a SevenGo proTM F- electrode, Mettler 
Toledo, France). Finally, the MMAD of nebulized particles was calculated using 
electrochemical measurements of sodium fluoride. 
Likewise, a gravimetric study of aerosol was conducted to determine the effect of acoustic 
airflow of the different nebulizing systems on the total aerosol mass output during a 
nebulization experiment. The study was performed using sodium fluoride (NaF; 1%; 1.5 ml) 
as recommended by European standard procedure (NF EN 13544-1) and following the 
previously described experimental procedure (Durand et al., 2011). The nebulizer was filled 
with NaF solution and connected to its corresponding compressor. An absolute filter 
(Inhalation Filter Pad, Pari GmbH, Germany), interposed between the nebulizing system and 
the respiratory pump (Compas2, Pari GmbH, Germany), was used for the collection of 
aerosol. The respiratory pump was regulated according to the mentioned above European 
standard (Sinus patter, Tidal volume of 500 ml, 15 breath/min, Inspiration: Expiration= 1:1). 
The amount of deposited aerosol was determined by weighing dry filters following a residual 
gravimetric method (Vecellio et al., 2004).  
 
2.6. Signal processing characterization of acoustic airflow 
The acoustic airflow superimposed on the aerosolized drug was characterized in order to 
understand its effect on the intrasinus drug deposition. C-weighted Sound level meter 
(EXTECH Instruments, USA), used for the measurement of the maximum sound pressure 
level, assembled to the data acquisition and recording system (ROGA Instruments, Germany) 
have been used to measure the acoustic airflow coming out of the nebulizers. After 
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measurement of the acoustic signal and recording it, spectral analysis was performed using 
short-time Fourier transform (STFT), that is a Fourier related transform used to determine the 
sinusoidal frequency of local sections of  shorter segments of a signal as it changes over time, 
for the determination of the frequency components (fundamental amplitude and potential 
harmonics). 
 
2.7. Statistical analysis 
Data of gentamicin concentration deposited into the maxillary sinuses obtained by FPIA as 
well as metrology study data were analyzed using Prism 5.0 software (GraphPad, SanDiego, 
CA). Graphs were plotted and significance *** (P<0.001) and ** (P<0.01) was established by 
two-way ANOVA test (p<0.05) for the gentamicin deposition study and one-way ANOVA 
test (p<0.05) for the metrology analysis. 
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3. Results 
3.1. Signal processing of acoustic airflow 
Two modes of acoustic airflow produced by different nebulizing systems were measured and 
analyzed for better understanding of the frequency components of each signal. Frequency 
components displayed on figure below (Fig. 2) were determined using the spectrogram of the 
short-time Fourier transform (STFT), which corresponds to its square modulus. On the 
representations of Fig. 2, the upper curve gives the signal in time, the left curve gives the 
modulus of the Fourier transform of the signal, and color image corresponds to the amplitude 
of the spectrogram (red = high, blue = low). The prevalent frequency component of the high 
frequency acoustic airflow is 200 Hz, which is the second harmonic of the fundamental 
frequency component of 100 Hz (Fig. 2). As can be observed, the signal is not purely 
sinusoidal and is relatively noisy, due to the resonances in the silicon tube. As for the second 
type of acoustic airflow, i.e. the low frequency acoustic airflow, it was observed that the 
signal possesses the fundamental component of 45 Hz, and it is a clean signal without noise 
(Fig. 2).  
 
3.2. Particle sizing and aerosol output 
The MMAD obtained were 2.75 ± 0.2 µm versus 2.25 ± 0.4 µm for the high frequency device 
(w versus w/o acoustic airflow respectively) and 3.3 ± 0.2 µm versus 3.3 ± 0.1 µm for the low 
frequency device (w versus w/o acoustic airflow respectively). Thus, results of aerosol 
particle size characterization have demonstrated that there is an insignificant (P= 0.4) impact 
of acoustic airflow on MMAD; however the MMAD of aerosol particles differs from one 
nebulizer to another depending on the design of the medical device (Fig. 5). Similarly, the 
output measurements of aerosol demonstrated insignificant decrease in output (ml) of 10% 
(from 0.62 ml to 0.55 ml) and of 21% (from 1.04 ml to 0.81 ml) upon superposition of the 
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high and low frequency acoustic airflow respectively, where the output rate of the high 
frequency acoustic airflow device is 0.2 ml/min versus 0.22 ml/min for the low frequency 
acoustic airflow device. Without acoustic airflow, about 41% of the initially introduced 
volume of NaF was nebulized by the low frequency acoustic airflow nebulizing system, and 
about 69% of this initial volume was nebulized by the high frequency acoustic airflow 
nebulizing system. Upon superposition of the acoustic airflow, the output fraction decreased 
to 37% and 54.5% in high and low frequency acoustic airflow respectively. 
 
3.3. Radioactive gas ventilation of maxillary sinuses w or w/o acoustic airflow 
Qualitative scintigraphic images of 81mKr-gas ventilation were acquired with and without the 
addition of acoustic airflow (Fig. 3).  
Referring to Fig. 3, to the part of the figure corresponding to the ventilation of 81mKr-gas 
without acoustic airflow through nebulizers, we can observe that only the nasal fossa was 
shown on the image in addition to the nebulizer coupled to the nasal plug. As a result, without 
the addition of acoustic airflow and independently of the nebulizer used, maxillary sinuses 
were not shown on the scintigraphic images indicating that there was no penetration of the 
81mKr-gas into them. 
Referring to the other part of the figure corresponding to the ventilation of 81mKr-gas with 
acoustic airflow through the nebulizers, upon superimposing the high frequency vibrating 
airflow on the aerosol delivered by the low frequency acoustic airflow nebulizing system, 
maxillary sinuses’ regions clearly appeared on the scintigraphic image. The image of the 
81mKr-gas ventilation using the low frequency vibrating acoustic airflow added shows similar 
sinus ventilation results.  
 
3. 4. Quantitative aerosol deposition into the maxillary sinuses 
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Impact of acoustic airflow on intra-sinus drug deposition is shown in Fig. 4. We have studied 
the effect of two different acoustic airflow modes: the high frequency and the low frequency 
pressure waves. The obtained results clearly demonstrate that: 
- Despite the type of acoustic airflow mode being superimposed on the nebulized drug, 
the intra-sinus drug deposition into both the left (LMS) and right maxillary sinuses 
(RMS) is relatively higher in the presence of acoustic airflow than in its absence. 
- Compared to aerosol deposition without acoustic airflow, the high frequency vibrating 
acoustic airflow superimposed onto the nebulized drug led to an increase of at least 4-
fold in gentamicin deposition into the LMS and 2-fold deposition increase into the 
RMS (Fig. 4).  
- Compared to aerosol deposition without acoustic airflow, the low frequency vibrating 
airflow superimposed on the drug nebulized has also demonstrated a significant 
increase of at least 4-fold for the RMS and 2-fold increase for the LMS (Fig. 4). 
- The concentration of gentamicin deposition into the left maxillary sinus was observed 
to be higher than its deposition into the right maxillary sinus despite the presence or 
absence of acoustic airflow. This is due to the morphological difference of the ostia of 
the plastic nasal replica (diameter of the LMS ostium is three times higher than that of 
the RMS ostium), as previously explained in one the former studies (Leclerc et al., 
2014a). 
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4. Discussion 
Impact of different modes of acoustic airflow on gas sinus ventilation 
The efficiency of application of the acoustic airflow to the nebulizing system for the 
enhancement of the radioactive 81mKr-gas ventilation through the maxillary sinuses has been 
clearly demonstrated. Without the application of acoustic airflow, 81mKr-gas wasn’t able to 
penetrate the poorly ventilated organs; thus, circulating in the nasal fossa only. However, in 
the presence of acoustic airflow, whatever the frequency value of the acoustic airflow, clear 
81mKr-gas ventilation through the MS was obtained. These results are in good accordance with 
the results published by Moeller et al. where the efficiency of the pulsating airflow was 
demonstrated by a significant increase in total 81mKr-gas activity in the MS of the nasal cast 
(Moeller et al., 2008). Similar conclusion has been drawn by Maniscalco et al. stating that 
humming leads to the enhancement in sinus nitric oxide (NO) levels when compared to silent 
exhalation (Maniscalco et al. 2003). In perfect coherence with these previous studies, our 
work clearly showed that sounding airflow leads to sinus ventilation regardless the frequency 
and intensity of the acoustic airflow. These factors, in addition to the geometrical dimensions 
of the maxillary ostia and MS, also play a significant role. 
Gas ventilation is a basic requirement to obtain an effective airborne drug delivery to the site 
of infectious disease; such as maxillary sinuses. The benefit of acoustic airflow to enhance the 
gas ventilation through the maxillary sinuses can be explained using the Helmholtz resonator 
theory. Maniscalco et al. demonstrated that an oscillating airflow produced by phonation 
caused a rise in the gas exchange between the nose and the paranasal sinuses. This gas 
ventilation was even more important when the frequency of the acoustic airflow was close to 
the resonant frequency of the sinus cavity (Maniscalco et al., 2006). In fact, a large cavity of 
air (e.g. a maxillary sinus) connected to a smaller diameter neck (e.g. an ostium) can resonate 
at a natural frequency according to the Helmholtz resonator theory (Vieweg, 1863). As a 
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result, the ventilation of secondary spaces can be achieved by applying a resonance frequency 
that is related to the geometry of the resonant system. If ostia connected to the maxillary 
sinuses are compared to Helmholtz resonators (Fig. 6), the resonance frequency can be 
calculated using the formula (Fig. 6) where ν is the speed of sound, A is the cross-sectional 
area of the ostium, V is the volume of the maxillary sinus, and l the length of the ostium. 
According to the Helmholtz resonator theory, we used a simple geometric model where the 
maxillary ostium is approximated as a cylindrical tube and the sinus as a sphere. The diameter 
and length of ostium as well as the volume of sinus were determined from CT scan. The 
volume of the sinus was 10 cm3 for the LMS and 14 cm3 for the RMS. We also assessed the 
geometric features the short and broad ostium of the LMS (diameter: 4-5 mm, length: 4-5 
mm) and the long and narrow ostium of the RMS (diameter: 3-4 mm, length: 7-8 mm). Then, 
applying the formula of the Helmholtz resonance, it can be assumed that the range of the 
theoretical resonant frequency were 150 Hz - 200 Hz for the RMS and 300 Hz - 400 Hz for 
the LMS. 
 
Impact of different modes of acoustic airflow on intrasinus drug deposition 
Studies of aerosol drug deposition into the maxillary sinuses under the influence of two 
different sound acoustic waves: the high frequency and the low frequency, performed on the 
plastic nasal replica, have demonstrated a significant influence of the acoustic airflow 
superposed on the airborne drug in the enhancement of intra-sinus drug deposition. In 
presence of acoustic airflow, a strong enhancement in the deposition of the nebulized 
gentamicin into the maxillary sinuses was observed after measuring the gentamicin 
concentration in the rinse liquid. Besides, a low amount of gentamicin was found at baseline 
in the MS w/o acoustic airflow although the major implication of 81mKr-gas results is that w/o 
acoustic airflow there should not be gas access to sinus cavities. We may explain this result by 
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the long medication delivery (above 10 min). As a result, there may be a huge drug overload 
in the nasal fossa. Moreover, a possible mucosa shrinking during plastination procedure may 
cause a slight enlargement of the ostia diameter. All things considered, although significant 
attention has been paid to the rinsing protocol to avoid biases, it is impossible to exclude that 
this medication overload may cause a slight washing of the drug from the nasal fossa into the 
sinus cavities.  
 
The two types of acoustic airflow investigated in our study have improved the intra-sinus drug 
penetration though at different degree of deposition, specifically when considering the left and 
right maxillary sinuses separately. Considering the impact of each acoustic airflow 
independently, it can be observed that the high frequency vibrating airflow has increased the 
gentamicin deposition by at least 2-fold in the right maxillary sinus and by 4-fold in the left 
maxillary sinus. With respect to the low frequency pressure wave, it can be clearly noticed 
from the obtained results that the drug deposition in the right maxillary sinus was increased by 
4-fold compared with the 2-fold increase in the left maxillary sinus.  
We previously demonstrated that the configuration of our nasal cast mainly serves as a 
decongested nasal unit in a living healthy human volunteer (Durand et al. 2010). In CRS 
patients, ostia are in part narrowed or completely blocked. This can limits the use of our cast 
to extrapolate results of aerosol transport to sinuses in CRS patients. However this work aims 
at studying the effect of different modes of acoustic airflow on aerosol drug penetration into 
maxillary sinuses for different ostia geometry (short and broad versus long and narrow). In 
this sense, the use of the nasal replica was useful and highly relevant. Besides Moeller et al. 
demonstrated that pulsating airflow enhances the aerosol deposition not only in healthy 
volunteers and CRS patients after FESS (i.e. with an opening that connects a sinus to the nasal 
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cavity), but also in CRS patients prior to FESS (i.e. with narrowed or completely obstructed 
ostium) (Möller et al. 2013). 
 
Referring to the results of aerosol particle sizing, it has been observed that superposition of 
the acoustic airflow on the nebulization left low impact on the aerosol particle size. With 
respect to the aerosol output, similar observation was made. Relating these observations to the 
results obtained in previously mentioned experiments, it might be said that the low frequency 
and the high frequency acoustic waves, which superposition on the nebulized aerosol left 
insignificant impact on the output of this aerosol.  
Focusing on the Helmholtz resonator theory (Moller et al., 2014; Vieweg, 1863) where the 
resonance frequency of the cavity is directly proportional to the geometry of the ostium, we 
rely in our explanation of the difference in the degree of increase in the drug deposition inside 
the sinuses on the geometrical variation of both sinuses of the replica. As mentioned earlier, 
the left ostium is shorter and broader than the right ostium which is longer and narrower. 
According to the formula of the Helmholtz resonance, it can be assumed that the short and 
broad ostium will require higher resonance frequency than the long and narrow ostium. 
Similarly, we can explain a stronger influence of low frequency acoustic airflow on the 
enhancement of the drug deposition into the right sinus when compared to the effect of high 
frequency airflow. Hence, with this perspective, our experimental results are in perfect 
accordance with the theory standing behind the Helmholtz resonator. The geometric features 
can in part explain why the high frequency acoustic airflow was more efficient in enhancing 
the drug deposition in the LMS than in the RMS. Nevertheless, we can notice a slight gap 
between the theoretical resonant frequency calculated from the Helmholtz resonance theory 
(150 Hz - 200 Hz for the RMS and 300 Hz - 400 Hz for the LMS) compared to the frequency 
of the acoustic airflow used for experimental measures of intrasinus drug deposition (100-
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200Hz for the high frequency acoustic airflow compared to 45Hz for the low frequency 
acoustic airflow). This difference may be due to the simple geometric approximation of the 
Helmholtz resonance theory (the ostium is approximated to a cylindrical tube and the sinus to 
a sphere) too far from anatomic features.   
Knowing that in patients with chronic rhinosinusitis, depending on the severity of the illness, 
the ostium of the maxillary sinus is either partially blocked or completely obstructed. Before 
reaching the maxillary sinuses, the drug first passes through the ostia. Depending on the 
degree of obstruction of the ostium, the concentration of drug penetrated into the sinuses 
varies. Our study therefore has pointed to the fact that for a given diameter of an ostium, a 
certain mode of acoustic airflow characterized by specific frequency should be more effective 
in enhancement of nebulized intra-sinus drug penetration compared to other acoustic airflow 
modes. Hence, in the light of results obtained in our study, we can make a hypothesis that 
using patient specific acoustic airflow (depending on the ostia geometry), improved treatment 
of CRS could be achieved in the future.  
However, a safe conclusion would be drawn after performing further studies on our nasal 
replica and clinical trials thereafter. As an example, a randomized, double-blind, placebo-
controlled pilot study was performed by Mainz et al. in cystic fibrosis patients with upper 
airway Pseudomonas aeruginosa colonization. According to the results obtained, the numbers 
of P. aeruginosa colonies were reduced in four of the six patients inhaling tobramycin 
sinonasally as vibrating aerosols but in none of the patients inhaling placebo (Mainz et al. 
2014). This pilot study showed that sinonasal inhalation of antibiotics applied as vibrating 
aerosols gave promise as a non-invasive method for the treatment of upper airway diseases. 
However, the severity of disease of each patient wasn’t specified, so we cannot conclude to 
what extent the maxillary ostia and its sinuses were obstructed. In this case, it was shown that 
the application of acoustic airflow enhances the deposition of aerosolized drug into poorly-
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ventilated cavities in general. It is also important to notice that our study focused on the MS 
but other nasal cavities are involved in CRS. Further study should be done to improve our 
understanding of the effect of acoustic airflow in paranasal sinuses including frontal sinus and 
ethmoidal sinuses. 
Although our results have been obtained from a model of a healthy non-congested subject, we 
have clearly demonstrated the positive impact of acoustic airflow on intra-sinus drug 
deposition generally and specifically at various rates depending on the frequency of the 
acoustic airflow and the geometry of the ostium. Therefore, it is safe to say that nebulized 
antibiotics under the effect of acoustic airflow are able to penetrate into the maxillary sinuses, 
as long as there is an access from the ostia. 
 
5. Conclusion 
We have demonstrated that a significant deposition of gentamicin into the maxillary sinuses 
was obtained in a human plastinated nasal cast upon superposition of the acoustic airflow on 
the nebulized drug. However, the degree of this deposition varied with the type of acoustic 
airflow being superimposed, and it also differed as a function of the geometric features of the 
ostia and the maxillary sinuses. High frequency acoustic airflow (200 Hz) has proved to be 
efficient in aerosolized drug deposition in shorter and broader ostium (LMS in our nasal 
replica) while the low frequency acoustic airflow (45 Hz) was more efficient in drug 
deposition into longer and narrower ostium (RMS in our nasal replica). Referring to the 
variation of anatomy between the ostia of the model; specifically the diameter of the ostia, we 
confirmed that for a given ostium geometry and sinus volume, there is a specific frequency 
resulting in the optimal drug deposition. For better targeting of maxillary sinuses of different 
degree of obstruction, a specific acoustic airflow has to be chosen for ensuring an effective 
treatment.  
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Figure 1. Experimental design of 81mKr-gas ventilation study. 
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Figure 2. Spectral analysis using Short-Time Fourier Transform (STFT) of the vibrating 
airflow generated by the two nebulizing systems. A) High frequency nebulizing system B) 
Low frequency nebulizing system. 
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Figure 3. Anterior gamma camera images of 81mKr-gas ventilation in a plastinated cast. (1) 
Right Maxillary Sinus (RMS) (2) Left Maxillary Sinus (LMS) (3) Nasal plug (4) Nebulizer. 
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Figure 4. Impact of high frequency and low frequency acoustic airflow on nebulized 
gentamicin collected in the maxillary sinuses (MS) in µg.ml-1. Nebulized physiological saline 
solution was used as the control (p<0.05). 
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Figure 5. Impact of high frequency and low frequency acoustic airflow on the variation in 
MMAD (in µm) of airborne particles. 
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Figure 6. Helmholtz resonator design. 
